For pharmaceutical and biotechnology companies focusing on research and development, prioritizing data transparency and clinical study reporting (CSR) is a ...

The 11th annual Bio Supply Management Alliance (BSMA) conference brought together leaders from across the life sciences supply chain community ...

Why have value-based arrangements been so slowly adopted in life sciences industries? What might the future model look like? These ...

Pharmaceutical organizations looking to grow into personalized medicine are leveraging high-dollar acquisitions of cell therapy companies to quickly enter the ...

Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of RNA interference therapeutics for genetically ...

The shift to personalized medicine, where companies can develop preventive measures and precision treatments to enhance a patient’s unique well-being, ...

Cell therapy, as defined by the American Society of Gene & Cell Therapy, is “the administration of living whole cells ...

2018 marked the 25th anniversary of the Biotechnology International Convention (BIO 2018). The annual convention was fittingly held in Boston, ...

For an emerging business to mature from a growth stage to a global success, the company’s organizational structure, process discipline, ...

Since quality management’s inception at the turn of the 20th century, life sciences business leaders have predominantly viewed the field ...

In 2008, the European Medicines Agency began discussing serialisation requirements for pharmaceutical manufacturers—if you’re unfamiliar with serialisation this video is ...

Just like the design-thinking revolution in software, we are in the midst of a patient-centered care revolution in healthcare. For ...